HOVIRAN Trademark

Trademark Overview


On Wednesday, March 20, 2024, a trademark application was filed for HOVIRAN with the United States Patent and Trademark Office. The USPTO has given the HOVIRAN trademark a serial number of 98459210. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by Changchun Tescon Biotechnology Co., Ltd.. The HOVIRAN trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, drugs; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test strips for breast milk analysis; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; pH test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; Pregnancy test kits for home use; Test strips for measuring blood glucose levels
hoviran

General Information


Serial Number98459210
Word MarkHOVIRAN
Filing DateWednesday, March 20, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Description of MarkThe mark consists of stylized wording "HOVIRAN".
Goods and ServicesDiagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol, drugs; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic test strips for breast milk analysis; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; pH test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; Pregnancy test kits for home use; Test strips for measuring blood glucose levels
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 20, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChangchun Tescon Biotechnology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChangchun, Jilin 130102
CN

Party NameChangchun Tescon Biotechnology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChangchun, Jilin 130102
CN

Trademark Events


Event DateEvent Description
Wednesday, March 20, 2024NEW APPLICATION ENTERED
Thursday, August 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 28, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 1, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, October 1, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 1, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 1, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED